NSN Co. Ltd

KQ:031860 Korea Diagnostics & Research
Market Cap
$5.02 Million
₩7.35 Billion KRW
Market Cap Rank
#31633 Global
#2083 in Korea
Share Price
₩406.00
Change (1 day)
-20.70%
52-Week Range
₩265.00 - ₩1709.00
All Time High
₩146500.00
About

DHX Company Co., Ltd. engages in biomedical and distribution businesses in South Korea. The company offers Microbiome to treat intractable skin diseases; REJURUB; and AI digital brain diagnostic device. It also purchases and distributes IT components, including graphics cards, DRAM, CPUs, high-capacity storage, and multi-purpose displays; import and distribution of cosmetics; f and b distribution… Read more

NSN Co. Ltd (031860) - Total Assets

Latest total assets as of September 2025: ₩60.96 Billion KRW

Based on the latest financial reports, NSN Co. Ltd (031860) holds total assets worth ₩60.96 Billion KRW as of September 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

NSN Co. Ltd - Total Assets Trend (2006–2024)

This chart illustrates how NSN Co. Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

NSN Co. Ltd - Asset Composition Analysis

Current Asset Composition (December 2024)

NSN Co. Ltd's total assets of ₩60.96 Billion consist of 35.8% current assets and 64.2% non-current assets.

Asset Category Amount (KRW) % of Total Assets
Cash & Equivalents ₩8.44 Billion 0.0%
Accounts Receivable ₩4.45 Billion 7.9%
Inventory ₩1.47 Billion 2.6%
Property, Plant & Equipment ₩5.24 Billion 9.3%
Intangible Assets ₩100.68 Million 0.2%
Goodwill ₩450.21 Million 0.8%

Asset Composition Trend (2006–2024)

This chart illustrates how NSN Co. Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: NSN Co. Ltd's current assets represent 35.8% of total assets in 2024, an increase from 0.0% in 2006.
  • Cash Position: Cash and equivalents constituted 0.0% of total assets in 2024, down from 4.2% in 2006.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2006.
  • Asset Diversification: The largest asset category is cash and equivalents at 0.0% of total assets.

NSN Co. Ltd Competitors by Total Assets

Key competitors of NSN Co. Ltd based on total assets are shown below.

Company Country Total Assets
ADCNF
OTCGREY:ADCNF
USA $4.51 Billion
Berry Genomics Co Ltd
SHE:000710
China CN¥2.34 Billion
Malaysian Genomics Resource
KLSE:0155
Malaysia RM20.70 Million
JOONGANG DNM Co.Ltd
KQ:051980
Korea ₩121.79 Billion
GeneMatrix Inc
KQ:109820
Korea ₩28.03 Billion
Genoray Co. Ltd
KQ:122310
Korea ₩125.67 Billion
Green Cross Lab Cell Corporation
KQ:144510
Korea ₩565.79 Billion
Optipharm.CO.LTD
KQ:153710
Korea ₩42.32 Billion

NSN Co. Ltd - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.10 - 0.47

Lower asset utilization - NSN Co. Ltd generates 0.17x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: -48.02% - -8.88%

Negative ROA - NSN Co. Ltd is currently not profitable relative to its asset base.

NSN Co. Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 0.95 3.96 2.16
Quick Ratio 0.82 3.38 2.06
Cash Ratio 0.00 0.49 0.00
Working Capital ₩-881.59 Million ₩ 7.58 Billion ₩ 12.27 Billion

NSN Co. Ltd - Advanced Valuation Insights

This section examines the relationship between NSN Co. Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 0.23
Latest Market Cap to Assets Ratio 0.00
Asset Growth Rate (YoY) -15.0%
Total Assets ₩56.16 Billion
Market Capitalization $4.54 Million USD

Valuation Analysis

Below Book Valuation: The market values NSN Co. Ltd's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: NSN Co. Ltd's assets decreased by 15.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for NSN Co. Ltd (2006–2024)

The table below shows the annual total assets of NSN Co. Ltd from 2006 to 2024.

Year Total Assets Change
2024-12-31 ₩56.16 Billion -15.02%
2023-12-31 ₩66.08 Billion -20.31%
2022-12-31 ₩82.93 Billion +27.76%
2021-12-31 ₩64.91 Billion +6.02%
2020-12-31 ₩61.22 Billion -10.40%
2019-12-31 ₩68.33 Billion +122.77%
2018-12-31 ₩30.67 Billion -5.80%
2017-12-31 ₩32.56 Billion -28.39%
2016-12-31 ₩45.47 Billion +15.99%
2015-12-31 ₩39.20 Billion +2.93%
2014-12-31 ₩38.09 Billion +7.29%
2013-12-31 ₩35.50 Billion -81.91%
2012-12-31 ₩196.25 Billion +14.69%
2011-12-31 ₩171.11 Billion +14.07%
2010-12-31 ₩150.00 Billion +526.43%
2007-12-31 ₩23.95 Billion +3.19%
2006-12-31 ₩23.21 Billion --